![](https://causaly.wpengine.com/wp-content/uploads/2024/02/Oncology-Research.jpg)
Enhance Your Search Sensitivity with AI: Off-Target Effects of BRAF
In contrast to conventional keyword searching techniques, Causaly’s AI can sift through and remove irrelevant data from biomedical searches, offering a more thorough and accurate understanding of entire research landscapes. This not only streamlines knowledge acquisition but ensures accuracy and precision in navigating the biomedical literature.
![](https://causalydev.wpengine.com/wp-content/uploads/2023/02/Anna-96x96.png)
February 29, 2024
![](https://causaly.wpengine.com/wp-content/uploads/2024/02/shutterstock_95758231-1.jpg)
Leveraging AI for Scientific Knowledge Extraction
AI is transforming the analysis of extensive biomedical data, allowing pharma companies to expedite R&D processes, and cut costs. By reaching conclusions quicker, the inclusion of AI in drug development pipelines can inform decision-making, enabling the prioritization of more promising research avenues.
![](https://causalydev.wpengine.com/wp-content/uploads/2023/02/Anna-96x96.png)
February 13, 2024
![](https://causaly.wpengine.com/wp-content/uploads/2024/01/Big-Data-Technology.jpg)
AI-Powered Drug Discovery: Identifying Safety Red Flags
Unmanageable toxicity accounts for 30% of clinical drug development failures and can cause severe side effects and potential harm to patients. Download our report to see how AI-powered drug discovery can help mitigate late-stage clinical failures and market withdrawals.
![](https://causalydev.wpengine.com/wp-content/uploads/2023/02/Anna-96x96.png)
January 30, 2024